CFGS
KRTX

Concourse Financial Group Securities’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Concourse Financial Group Securities’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1
Closed -$316 – 2379
2023
Q4 		$316 Buy
+1
New +$194 ﹤0.01% 2222

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Concourse Financial Group Securities's KRTX Position: Q1 2024 in Review

Concourse Financial Group Securities sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 1 share — an estimated $316 sold.

Concourse Financial Group Securities first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $316 in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Concourse Financial Group Securities reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Concourse Financial Group Securities sold 1 Karuna Therapeutics, Inc. Common Stock share in Q1 2024, an estimated $316.
  • Concourse Financial Group Securities first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Concourse Financial Group Securities's Karuna Therapeutics, Inc. Common Stock position peaked at $316 in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Concourse Financial Group Securities's 13F filing for Q1 2024, filed 1 May 2024.